Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Archive for August, 2009

Big stage for diabetes hopeful

Friday, August 28th, 2009

Recent regulatory setbacks aside, Takeda Pharmaceutical Co. is plowing full steam ahead on its quest to win approval for the company’s key type 2 diabetes drug alogliptin, another potential entrant into the suddenly competitive field of DPP-4 inhibitors. The Japanese drug giant said today that it received the “all-clear” from FDA ...

Progress against swine flu as Novartis begins human tests

Wednesday, August 5th, 2009

As swine flu spreads across 168 countries and territories, another company has begun testing a vaccine in humans. Novartis has begun the company’s first human tests in 6,000 people in a year-long trial in Britain, Germany, and the United States. Last month CSL Ltd., an Australian biopharmaceutical company, became the ...

   
©2012 UBM Canon